Stop Codon: Definition, Function, and Role in Translation

By Dr. Zubair Khalid, DVM, MS, PhD ·

Stop Codon: Definition, Function, and Role in Translation

Introduction to Stop Codons

A stop codon is a three-nucleotide sequence within messenger RNA (mRNA) that signals the end of protein synthesis during translation. When the ribosome encounters a stop codon in the ribosomal A site, it does not recruit an aminoacyl-tRNA. Instead, the stop codon triggers a series of molecular events that culminate in the hydrolysis of the completed polypeptide chain from the peptidyl-tRNA and the subsequent disassembly of the translational machinery. The three standard stop codons are UAA, UAG, and UGA, where U, A, and G denote the RNA bases uracil, adenine, and guanine, respectively.

Stop codons are sometimes referred to as termination codons or nonsense codons, the latter term reflecting the fact that they do not correspond to any amino acid. The term "nonsense" is also used in the context of mutations that create premature stop codons, which will be discussed in detail later. Understanding stop codons requires a firm grasp of the genetic code, the universal language by which nucleotide sequences are translated into amino acid sequences.

The Genetic Code and Stop Signals

The genetic code is degenerate, meaning that most amino acids are specified by more than one codon. Of the 64 possible triplet codons, 61 encode the 20 standard amino acids, and three—UAA, UAG, and UGA—serve as termination signals. These three codons are recognized not by tRNAs carrying amino acids but by proteins called release factors (RFs) that bind to the ribosome and promote peptide release.

The assignment of UAA, UAG, and UGA as stop codons is nearly universal across all domains of life, from bacteria to archaea to eukaryotes. However, there are notable exceptions. In many mitochondrial genomes, for example, UGA codes for tryptophan rather than serving as a stop signal. Some ciliates, such as Tetrahymena thermophila, reassign UAA and UAG to encode glutamine. These deviations underscore the evolutionary plasticity of the genetic code while highlighting the near-universal conservation of the three canonical stop codons in nuclear genomes.

The relationship between codons and amino acids is typically visualized using a Codon Table or a Codon Wheel. These tools allow you to quickly identify that UAA, UAG, and UGA are the only triplets that do not specify an amino acid. A related concept is the Codon Definition, which formally describes a codon as a trinucleotide sequence that either specifies an amino acid or signals termination.

Why Stop Codons Are Essential

Stop codons serve several critical functions in gene expression. First, they define the boundaries of the open reading frame (ORF), the continuous stretch of codons that begins with a Start Codon (typically AUG) and ends with a stop codon. Without stop codons, ribosomes would continue translating past the intended end of the coding sequence, producing aberrant proteins with extended C-termini that could misfold or aggregate.

Second, stop codons are essential for ribosome recycling. After termination, the ribosome must be released from the mRNA and split into its 40S and 60S subunits (in eukaryotes) or 30S and 50S subunits (in bacteria) so that it can participate in new rounds of translation. The stop codon recognition event initiates this recycling process.

Third, stop codons play a regulatory role in gene expression. The efficiency of termination at a stop codon can vary depending on the surrounding nucleotide context, and this variability can be exploited by cells to regulate the production of alternative protein isoforms. Additionally, stop codons are targets for programmed readthrough, a process by which ribosomes occasionally bypass a stop codon and continue translation into the 3' untranslated region (UTR), producing a C-terminally extended protein.

The Three Stop Codons and Their Recognition

The three stop codons—UAA, UAG, and UGA—are recognized by release factors, proteins that mimic tRNAs in shape and size but do not carry amino acids. The mechanism of recognition differs between prokaryotes and eukaryotes, reflecting the distinct release factor repertoires in these domains of life.

Release Factors in Prokaryotes

In bacteria, two class I release factors mediate stop codon recognition: RF1 and RF2. RF1 recognizes UAA and UAG, while RF2 recognizes UAA and UGA. Both RF1 and RF2 share a conserved tripeptide motif—PxT in RF1 and SPF in RF2—that directly contacts the stop codon nucleotides in the decoding center of the 30S ribosomal subunit. This motif is responsible for the codon specificity of each factor.

The recognition process begins when a stop codon enters the ribosomal A site. RF1 or RF2 binds to the A site, where it establishes base-specific contacts with the stop codon. The binding of the release factor induces a conformational change in the ribosome that triggers the hydrolysis of the ester bond linking the completed polypeptide to the tRNA in the P site. This hydrolysis reaction is catalyzed by the peptidyl transferase center of the 50S subunit, which is composed of ribosomal RNA rather than protein.

A third factor, RF3, is a GTPase that facilitates the dissociation of RF1 or RF2 from the ribosome after peptide release. RF3 binds to the ribosome in its GDP-bound form, and upon peptide release, it exchanges GDP for GTP, undergoes a conformational change, and promotes the release of the class I factor. GTP hydrolysis by RF3 then allows RF3 itself to dissociate, leaving the ribosome ready for recycling by ribosome recycling factor (RRF) and elongation factor G (EF-G).

Release Factors in Eukaryotes

Eukaryotes employ a single class I release factor, eRF1, which recognizes all three stop codons (UAA, UAG, and UGA). eRF1 is a three-domain protein: the N-terminal domain contains the codon recognition determinants, the middle domain harbors the GGQ motif that is essential for peptidyl-tRNA hydrolysis, and the C-terminal domain mediates interactions with eRF3, the eukaryotic release factor 3.

eRF3 is a GTPase that, like bacterial RF3, stimulates peptide release but is not strictly required for it. In the presence of eRF3 and GTP, eRF1 binds to the ribosome with higher affinity and the rate of peptide release is accelerated. The eRF1–eRF3–GTP complex recognizes the stop codon in the A site, and upon codon recognition, GTP is hydrolyzed by eRF3, triggering a conformational change that positions the GGQ motif of eRF1 in the peptidyl transferase center. This positioning allows the GGQ motif to coordinate a water molecule that attacks the ester bond of the peptidyl-tRNA, releasing the completed polypeptide.

A notable feature of eukaryotic termination is that eRF1 can recognize all three stop codons, whereas bacteria require two separate factors. This difference has implications for the evolution of the genetic code and for the design of experiments that manipulate stop codon identity in different organisms.

Mechanism of Translation Termination

Translation termination is a highly coordinated process that involves the precise recognition of the stop codon, the hydrolysis of the peptidyl-tRNA bond, and the recycling of ribosomal subunits. The following steps outline the mechanism in molecular detail.

Peptidyl-tRNA Hydrolysis

  1. Stop codon entry into the A site: During the elongation phase of translation, the ribosome moves along the mRNA in a 5' to 3' direction. When a stop codon (UAA, UAG, or UGA) enters the A site, no aminoacyl-tRNA with a complementary anticodon exists to bind it. This creates a pause in elongation.
  1. Release factor binding: In bacteria, RF1 or RF2 binds to the A site, recognizing the stop codon through direct base-specific contacts. In eukaryotes, the eRF1–eRF3–GTP complex binds. The release factor occupies a space similar to that of a tRNA, but its interactions with the stop codon are mediated by protein–RNA contacts rather than codon–anticodon base pairing.
  1. Conformational rearrangement: The binding of the release factor triggers a conformational change in the ribosome, particularly in the decoding center and the peptidyl transferase center. This rearrangement positions a conserved motif of the release factor—the GGQ motif in both bacterial and eukaryotic release factors—adjacent to the peptidyl-tRNA ester bond.
  1. Hydrolysis of the ester bond: The GGQ motif coordinates a water molecule that performs a nucleophilic attack on the carbonyl carbon of the ester bond linking the polypeptide to the tRNA in the P site. This hydrolysis reaction releases the completed polypeptide from the tRNA, and the polypeptide exits the ribosome through the nascent polypeptide exit tunnel.
  1. Release factor dissociation: After peptide release, the release factor must dissociate from the ribosome. In bacteria, RF3 (a GTPase) promotes the dissociation of RF1 or RF2. In eukaryotes, eRF3 hydrolyzes GTP, which triggers a conformational change in eRF1 that reduces its affinity for the ribosome, allowing it to dissociate.

Ribosome Recycling

After the polypeptide is released, the ribosome remains bound to the mRNA with a deacylated tRNA in the P site and the stop codon in the A site. This post-termination complex must be disassembled to free the ribosomal subunits for new rounds of translation.

In bacteria, ribosome recycling factor (RRF) and elongation factor G (EF-G) work together to split the ribosome into its 30S and 50S subunits. RRF binds to the A site of the post-termination complex, mimicking a tRNA. EF-G, in its GTP-bound form, then binds to the ribosome and, upon GTP hydrolysis, drives a conformational change that separates the subunits. The 30S subunit remains bound to the mRNA, and the deacylated tRNA is released. The mRNA is then available for new initiation events.

In eukaryotes, the recycling process involves the ATP-binding cassette protein ABCE1 (also known as Rli1 in yeast). ABCE1 binds to the post-termination complex and, using the energy of ATP hydrolysis, splits the ribosome into its 40S and 60S subunits. The 40S subunit, still associated with the mRNA, can then be recycled for new rounds of translation. The precise molecular details of eukaryotic ribosome recycling are still being elucidated, but the overall scheme parallels the bacterial mechanism.

Stop Codon Mutations and Their Consequences

Mutations that alter stop codons can have profound effects on gene expression and protein function. The most well-studied class of such mutations is the nonsense mutation, which converts a sense codon (encoding an amino acid) into a premature stop codon.

Nonsense-Mediated Decay

A premature stop codon (PTC) is a stop codon that appears before the normal termination site within the coding sequence. When a ribosome encounters a PTC, it terminates translation prematurely, producing a truncated protein that lacks the C-terminal portion of the full-length polypeptide. Such truncated proteins are often nonfunctional and can exert dominant-negative effects if they retain some activity but lose regulatory domains.

To prevent the accumulation of truncated proteins, eukaryotic cells have evolved a surveillance mechanism called nonsense-mediated mRNA decay (NMD). NMD recognizes mRNAs that contain PTCs and targets them for degradation. The key determinant for NMD in mammals is the position of the stop codon relative to the last exon–exon junction. During splicing, a complex of proteins called the exon junction complex (EJC) is deposited upstream of each exon–exon junction. In a normal mRNA, the stop codon is typically located in the last exon, and the ribosome displaces all EJCs during the first (pioneer) round of translation. However, if a PTC is located more than 50–55 nucleotides upstream of the last exon–exon junction, the ribosome terminates before it can displace the downstream EJCs. The remaining EJCs recruit the NMD machinery, which triggers mRNA degradation.

NMD is not limited to mutant mRNAs; it also regulates the expression of naturally occurring transcripts that contain PTCs, such as those produced by alternative splicing that introduces premature termination codons. This makes NMD an important post-transcriptional regulatory mechanism.

Examples of Genetic Disorders

Nonsense mutations are responsible for a substantial fraction of inherited genetic disorders. For example, in cystic fibrosis, approximately 10% of disease-causing mutations are nonsense mutations in the CFTR gene, which encodes the cystic fibrosis transmembrane conductance regulator. The most common nonsense mutation, G542X, introduces a premature UGA stop codon at position 542 of the 1,480-amino-acid protein. The resulting truncated CFTR protein is nonfunctional, leading to the characteristic defects in chloride ion transport.

Similarly, Duchenne muscular dystrophy (DMD) is often caused by nonsense mutations in the DMD gene, which encodes dystrophin, a large cytoskeletal protein. Approximately 10–15% of DMD cases are due to premature stop codons. The truncated dystrophin protein is unable to link the actin cytoskeleton to the extracellular matrix, leading to muscle fiber degeneration.

The clinical severity of nonsense mutations depends on the position of the PTC and the efficiency of NMD. If the PTC is located near the 3' end of the coding sequence, the truncated protein may retain partial function, resulting in a milder phenotype. Conversely, PTCs located early in the coding sequence typically produce severely truncated proteins that are rapidly degraded.

Stop Codon Readthrough and Suppression

Although stop codons are generally recognized as termination signals, they can occasionally be misinterpreted. Two mechanisms account for this: suppressor mutations and programmed readthrough.

Suppressor Mutations

Suppressor mutations are mutations that restore protein function in the presence of a primary mutation, often by altering the translational machinery. In the context of stop codons, suppressor tRNAs are mutant tRNAs whose anticodons have been changed to recognize a stop codon. For example, a tRNA that normally carries tryptophan (anticodon CCA) can be mutated to have an anticodon that base-pairs with UGA (anticodon UCA). This suppressor tRNA would insert tryptophan at UGA codons, allowing translation to continue past the stop signal.

Suppressor tRNAs have been extensively studied in bacteria, where they were instrumental in deciphering the genetic code. For instance, the supF suppressor tRNA in Escherichia coli recognizes UAG and inserts tyrosine. Suppressor tRNAs are also used as tools in molecular biology to study protein function by introducing amino acid analogs at specific positions.

However, suppressor tRNAs are not perfectly efficient. They compete with release factors for binding to the stop codon, and the outcome depends on the relative concentrations of the suppressor tRNA and the release factor, as well as the nucleotide context surrounding the stop codon. In eukaryotic cells, suppressor tRNAs are less common, and their use is complicated by the fact that eRF1 recognizes all three stop codons with high affinity.

Programmed Readthrough in Viruses

Programmed readthrough is a regulated process by which a stop codon is deliberately bypassed at a defined frequency, allowing translation to continue into the downstream sequence. This mechanism is particularly common in RNA viruses, where it is used to produce fusion proteins from overlapping open reading frames.

A classic example is the gag-pol polyprotein of retroviruses such as Moloney murine leukemia virus (MoMLV). The gag and pol genes are in the same reading frame but are separated by a UAG stop codon. In approximately 5–10% of translation events, the ribosome reads through this stop codon, incorporating glutamine (the amino acid specified by the suppressor tRNA that recognizes UAG) and continuing into the pol sequence. The resulting gag-pol fusion protein is then cleaved by the viral protease to release the reverse transcriptase and integrase enzymes.

Programmed readthrough requires specific cis-acting elements in the mRNA, including the stop codon itself and downstream stimulatory sequences. In MoMLV, a pseudoknot structure downstream of the UAG codon promotes readthrough by causing the ribosome to pause, increasing the probability that a suppressor tRNA will bind instead of a release factor. The efficiency of readthrough is typically low (1–10%), which ensures that the correct stoichiometric ratio of structural proteins (gag) to enzymatic proteins (gag-pol) is maintained.

Methods to Study Stop Codons

Studying stop codons requires experimental approaches that can measure termination efficiency, identify the factors involved, and assess the consequences of mutations. Several techniques are commonly used in research and teaching laboratories.

Dual-Luciferase Reporter Assay

The dual-luciferase reporter assay is a quantitative method for measuring stop codon readthrough or termination efficiency. In this assay, two luciferase genes are fused in-frame, with the test stop codon placed between them. The upstream gene encodes Renilla luciferase, and the downstream gene encodes firefly luciferase. When translation terminates at the test stop codon, only Renilla luciferase is produced. When readthrough occurs, a fusion protein containing both luciferases is produced.

The assay is performed by transfecting cells with the reporter construct and, after a suitable incubation period (typically 24–48 hours), lysing the cells and measuring both luciferase activities. The ratio of firefly to Renilla activity provides a direct measure of readthrough efficiency. For example, if the firefly/Renilla ratio is 0.05, readthrough occurred in 5% of translation events.

This assay is highly sensitive and can be adapted to test the effects of different stop codons, flanking sequences, or mutations in release factors. It is also used to screen for drugs that promote readthrough of premature stop codons, a therapeutic strategy for genetic disorders caused by nonsense mutations.

CRISPR-Cas9 Mutagenesis

CRISPR-Cas9 technology has revolutionized the study of stop codons by enabling precise genome editing. Researchers can introduce or remove stop codons at specific loci to study their effects on gene expression. For example, a stop codon can be introduced into a gene of interest to create a model of a nonsense mutation, and the resulting phenotype can be characterized.

The typical workflow involves designing a single-guide RNA (sgRNA) that targets the Cas9 nuclease to the desired genomic locus. A donor DNA template containing the desired mutation (e.g., a stop codon) is co-delivered with the Cas9-sgRNA complex. Homology-directed repair (HDR) then incorporates the mutation into the genome. After editing, cells are screened by PCR and sequencing to confirm the presence of the stop codon.

CRISPR-Cas9 has also been used to study the role of stop codon context. By systematically varying the nucleotides surrounding a stop codon, researchers can identify sequence elements that influence termination efficiency. This approach has revealed that the identity of the nucleotide immediately following the stop codon (the +4 position) is a major determinant of termination efficiency. In eukaryotes, UAAU and UGAC are strong termination signals, whereas UAAA and UGAA are weaker.

Common Misconceptions and Pitfalls

Students often encounter several conceptual difficulties when learning about stop codons. Addressing these misconceptions is essential for a correct understanding of translation.

Stop Codons Do Not Code for Amino Acids

A frequent error is to think of stop codons as coding for a "stop amino acid" or to include them in the list of amino acid-specifying codons. Stop codons are not recognized by tRNAs and do not direct the incorporation of any amino acid. Instead, they are recognized by release factors, which are proteins, not tRNAs. The distinction is fundamental: tRNAs carry amino acids and read codons through codon–anticodon base pairing, whereas release factors recognize stop codons through protein–RNA interactions and catalyze peptide release.

This misconception can lead to errors when reading a Codon Table. The three stop codons are typically marked with "Stop" or a similar designation, and they should never be assigned an amino acid. When using a Codon Wheel, the same principle applies: the inner circle will show "Stop" for UAA, UAG, and UGA.

Context-Dependent Termination Efficiency

Another common pitfall is assuming that all stop codons are recognized with equal efficiency. In reality, termination efficiency is strongly influenced by the surrounding nucleotide context. The nucleotide immediately downstream of the stop codon (the +4 position) is particularly important. In E. coli, UAAU is the most efficient termination signal, while UGAU is the least efficient. In eukaryotes, the context is also important, with UAAU and UGAC being strong signals and UAAA being weak.

This context dependence has practical implications. When designing experiments that involve stop codons, researchers must consider the flanking sequences. For example, when constructing a reporter gene with a stop codon, the choice of the +4 nucleotide can significantly affect the measured readthrough efficiency. Similarly, when using Codon Optimization Tool Free software to design genes for heterologous expression, the choice of stop codon and its context can influence protein yield.

Confusing Stop Codons with Start Codons

Students sometimes confuse stop codons with the Starting Codon (AUG). While both are involved in defining the coding sequence, they have opposite functions. The start codon initiates translation and codes for methionine (in eukaryotes) or formylmethionine (in bacteria). Stop codons terminate translation and code for nothing. Additionally, the start codon is recognized by a specialized initiator tRNA, whereas stop codons are recognized by release factors.

The distinction is also important in the context of the Codon Anticodon interaction. The start codon AUG pairs with the anticodon UAC of the initiator tRNA. Stop codons have no corresponding anticodon because no tRNA recognizes them.

Summary and Key Takeaways

Stop codons are essential components of the genetic code that define the boundaries of protein-coding sequences. The three stop codons—UAA, UAG, and UGA—are recognized by release factors, which trigger the hydrolysis of the peptidyl-tRNA bond and the release of the completed polypeptide. Mutations that create premature stop codons can cause disease, but cells have evolved surveillance mechanisms such as NMD to mitigate their effects. Stop codons can also be bypassed through suppressor tRNAs or programmed readthrough, mechanisms that are exploited by viruses and that have therapeutic potential.

Frequently Asked Questions

What is a stop codon?

A stop codon is a three-nucleotide sequence in mRNA that signals the termination of protein synthesis. The three stop codons are UAA, UAG, and UGA. When a ribosome encounters a stop codon in the A site, it does not recruit a tRNA but instead binds a release factor that triggers the release of the completed polypeptide.

What are the three stop codons?

The three stop codons are UAA (often called ochre), UAG (amber), and UGA (opal). These names are historical and derive from the bacterial strains in which they were first characterized. All three are recognized by the eukaryotic release factor eRF1, while bacteria use two factors: RF1 (UAA and UAG) and RF2 (UAA and UGA).

What does a stop codon do?

A stop codon terminates translation. It is recognized by a release factor, which promotes the hydrolysis of the ester bond linking the completed polypeptide to the tRNA in the P site. This releases the polypeptide from the ribosome, after which the ribosomal subunits are recycled for new rounds of translation.

Can a stop codon code for an amino acid?

No. Stop codons do not code for any amino acid. They are not recognized by tRNAs and do not direct the incorporation of an amino acid into the growing polypeptide chain. Instead, they are recognized by protein release factors.

What happens if a stop codon is mutated?

If a stop codon is mutated to a sense codon, translation will continue past the normal termination site, producing a protein with an extended C-terminus. If a sense codon is mutated to a premature stop codon, translation will terminate early, producing a truncated protein. Premature stop codons often trigger nonsense-mediated mRNA decay, which degrades the mRNA before a truncated protein can be produced.

What is an example of a stop codon?

UAA is an example of a stop codon. In the sequence 5'-AUG GCC UAA-3', the ribosome would translate AUG (methionine) and GCC (alanine), then terminate at UAA, releasing a dipeptide (Met-Ala).

What is the process of stop codon recognition?

Stop codon recognition begins when a stop codon enters the ribosomal A site. A release factor (RF1 or RF2 in bacteria; eRF1 in eukaryotes) binds to the A site and establishes base-specific contacts with the stop codon. This binding induces a conformational change that positions the GGQ motif of the release factor in the peptidyl transferase center. The GGQ motif coordinates a water molecule that hydrolyzes the ester bond of the peptidyl-tRNA, releasing the polypeptide. The release factor then dissociates, and the ribosome is recycled.

Key Takeaways

  • Stop codons (UAA, UAG, UGA) are translation termination signals that do not code for amino acids.
  • Release factors (RF1/RF2 in bacteria, eRF1 in eukaryotes) recognize stop codons and catalyze peptidyl-tRNA hydrolysis.
  • Termination involves stop codon recognition, peptide release, and ribosome recycling, each with distinct molecular players.
  • Nonsense mutations create premature stop codons, leading to truncated proteins and often triggering nonsense-mediated mRNA decay.
  • Stop codon readthrough can occur via suppressor tRNAs or programmed readthrough, the latter being important in viral gene expression.
  • Termination efficiency is context-dependent, influenced by flanking nucleotides, particularly the +4 position.
  • Experimental tools such as dual-luciferase reporters and CRISPR-Cas9 mutagenesis are essential for studying stop codon function.

Further Reading

  • Rodnina MV. Translation in Prokaryotes. Cold Spring Harbor perspectives in biology. 2018. PubMed 29661790
  • Roberts TC, Wood MJA, Davies KE. Therapeutic approaches for Duchenne muscular dystrophy. Nature reviews. Drug discovery. 2023. PubMed 37652974
  • Kubaski F et al. Mucopolysaccharidosis Type I. Diagnostics (Basel, Switzerland). 2020. PubMed 32188113
  • Ohama T et al. Evolving genetic code. Proceedings of the Japan Academy. Series B, Physical and biological sciences. 2008. PubMed 18941287
  • Cobucci-Ponzano B, Rossi M, Moracci M. Recoding in archaea. Molecular microbiology. 2005. PubMed 15659155
  • Potapova NA. Nonsense Mutations in Eukaryotes. Biochemistry. Biokhimiia. 2022. PubMed 35790376

Related Clinical & Scientific Guides